comparemela.com

Biomarker Solution Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) June 13, 2023 This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will

United kingdomVera kovacevicKatherinet landschulzMohammad shadab siddiquiMargerya connellyHoneycomb worldwide incVirginia commonwealth universityBiomarker solution centerDrug developmentStrategic directorSenior directorTherapeutic area leadRenal diseaseNeurodegenerative diseasesAssociate professorNon invasive approaches

Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) October 12, 2022 Diagnosing and assessing the progression of nonalcoholic steatohepatitis (NASH) continue to be some of the most

United kingdomMargerya connellyKatherinet landschulzClaudia filozofLara dimick santosVera kovacevicLabcorp drug developmentHoneycomb worldwide incBiomarker solution centerVice presidentLiver therapeutic areaSenior directorTherapeutic area leadExecutive medical directorStrategic directorHow non invasive biomarkers

Discovery Life Sciences Appoints Chief Scientific Officer to Drive Company s Rapid Global Expansion of Biomarker Services

/PRNewswire/ Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, announced that Suso J. Platero, Ph.D., has joined the company.

Glenn bilawskySusoj plateroBristol myers squibbVertex pharmaceuticalsDiscovery life sciencesResearch use onlyBiomarker solution centerJanssen pharmaceutical companies of johnsonLife sciencesBiomarker specialistsGene therapyJanssen pharmaceutical companiesClinical biomarkers

Immuno-Oncology – Converting Cancer to a Chronic Disease, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) November 04, 2021 The treatment of a cancer patient with immunotherapies offers unparalleled innovation that harnesses the immune

United statesRavi karraDirk schadendorfMariaj prendesLabcorp drug developmentHoneycomb worldwide incBiomarker solution centerDepartment of dermatologyUniversity hospital essenSenior director oncologyConverting cancerLife sciencePress release

vimarsana © 2020. All Rights Reserved.